Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE0005659700
Mon, 27.01.2025
Eckert & Ziegler SE
Financial Year 2024 (preliminary):
Sales of around EUR 295 million (previous year: EUR 246.1 million)
EBIT before special items of around EUR 66 million (previous year: EUR 46.9 million)
Net Income of around EUR 33 million (previous year: EUR 26.3 million)
Berlin, 27 January 2025. According to preliminary, unaudited figures, Eckert & Ziegle [ … ]
Tue, 14.01.2025
Eckert & Ziegler SE
Berlin, 14 January 2025. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) today signed a licence agreement with Qi Kang Medical, Ltd (QKM), a joint venture between Eckert & Ziegler and the Chinese company DC Pharma, for the cyclotron technology used by Eckert & Ziegler to manufacture Ac-225. The contract guarantees Eckert & Ziegler a [ … ]
Mon, 13.01.2025
Eckert & Ziegler SE
Berlin, Germany and Sydney, Australia, 13. January 2025. Eckert & Ziegler (ISIN DE0005659700, SDAX) and GlyTherix Ltd (GlyTherix), an Australian targeted radiotherapy company specialising in developing antibody radiopharmaceuticals for solid tumors, today announced the expansion of their existing Lutetium-177 based collaboration with a global s [ … ]